Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDOrgenesis Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $0.40 | $0.40 | $0.40 |
| Q2 2024 | 1 | $1.37 | $1.43 | $1.40 |
| Q3 2024 | 1 | $1.70 | $1.70 | $1.70 |
| Q4 2024 | 1 | $2.50 | $2.50 | $2.50 |
Orgenesis Inc. Earnings Date And Information
Orgenesis Inc. last posted its earnings results on Monday, November 13th, 2023. The company reported $-4.3 earnings per share for the quarter, missing analysts' consensus estimates of $0.1 by $4.4. The company had revenue of 347,000 for the quarter and had revenue of 530,000 for the year. Orgenesis Inc. has generated $-2 earnings per share over the last year ($-1.91 diluted earnings per share) and currently has a price-to-earnings ratio of -3.19. Orgenesis Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 13th, 2024 based on prior year's report dates.
Orgenesis Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$0.19 | $18.50 M | $347,000 | ||
| 08/08/2024 | Q2 2024 | -$0.23 | $15.70 M | $246,000 | ||
| 05/20/2024 | Q1 2024 | -$0.29 | $141,000 | |||
| 04/15/2024 | Q4 2023 | -$1.09 | $-13,599,000 | |||
| 04/15/2024 | Q3 2023 | $0.43 | $13.50 M | $110,000 | ||
| 04/15/2024 | Q2 2023 | -$0.15 | $10.70 M | $6.98 M | ||
| 04/15/2024 | Q1 2023 | -$0.16 | $7.04 M | |||
| 03/22/2023 | Q4 2022 | -$0.05 | $13.62 M | |||
| 11/10/2022 | Q3 2022 | -$0.20 | -$0.06 | 0.14 | $7.30 M | $7.99 M |
| 08/15/2022 | Q2 2022 | -$0.22 | $7.00 M | $7.20 M | ||
| 05/23/2022 | Q1 2022 | -$0.40 | -$0.16 | 0.24 | $7.21 M | |
| 03/30/2022 | Q4 2021 | -$0.06 | -$0.21 | -0.15 | $6.89 M | |
| 11/04/2021 | Q3 2021 | -$0.35 | -$0.42 | -0.07 | $9.00 M | $8.68 M |
| 08/05/2021 | Q2 2021 | -$0.23 | -$0.11 | 0.12 | $3.30 M | $10.55 M |
| 05/06/2021 | Q1 2021 | -$0.01 | $9.39 M | |||
| 03/09/2021 | Q4 2020 | -$2.34 | $2.30 M | |||
| 11/05/2020 | Q3 2020 | -$0.11 | $13.70 M | $1.73 M | ||
| 08/06/2020 | Q2 2020 | -$0.95 | $11.40 M | $1.75 M | ||
| 05/08/2020 | Q1 2020 | -$0.20 | $4.23 | 4.43 | $1.88 M | |
| 03/09/2020 | Q4 2019 | -$0.27 | -$0.34 | -0.07 | $9.08 M |
Orgenesis Inc. Earnings: FAQ's
When is Orgenesis Inc.'s earnings date?
Orgenesis Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 13th, 2024 based off last year's report dates.
How can I listen to Orgenesis Inc.'s earnings conference
call?
The conference call for Orgenesis Inc.'s latest earnings report can be listened to online.
How can I read Orgenesis Inc.'s conference call transcript?
The conference call transcript for Orgenesis Inc.'s latest earnings report can be read online.
How much revenue does Orgenesis Inc. generate each year?
Orgenesis Inc. (:ORGS) has a recorded annual revenue of $530,000.
How much profit does Orgenesis Inc. generate each year?
Orgenesis Inc. (:ORGS) has a recorded net income of $530,000. Orgenesis Inc. has generated $-1.91 earnings per share over the last four quarters.
What is Orgenesis Inc.'s price-to-earnings ratio?
Orgenesis Inc. (:ORGS) has a price-to-earnings ratio of -3.19 and price/earnings-to-growth ratio is 0.06.